about
Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccinationEvaluation of the inclusion of a mixture of organic acids or lactulose into the feed of pigs experimentally challenged with Salmonella Typhimurium.Cytokine profiles and phenotype regulation of antigen presenting cells by genotype-I porcine reproductive and respiratory syndrome virus isolates.Immunosuppression in postweaning multisystemic wasting syndrome affected pigs.Immunology of porcine circovirus type 2 (PCV2).Anti-HEV antibodies in domestic animal species and rodents from Spain using a genotype 3-based ELISA.Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses.Comparison of protocols for the analysis of type 1 porcine reproductive and respiratory syndrome virus by RT-PCR using oral fluids.Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in conventional pigs.Impact of genotype 1 and 2 of porcine reproductive and respiratory syndrome viruses on interferon-α responses by plasmacytoid dendritic cells.Temporal evolution and potential recombination events in PRRSV strains of Sonora Mexico.Regulation of toll-like receptors 3, 7 and 9 in porcine alveolar macrophages by different genotype 1 strains of porcine reproductive and respiratory syndrome virus.Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infectionGenetic characterization of the complete coding regions of genotype 3 hepatitis E virus isolated from Spanish swine herds.Genetic and immunobiological diversities of porcine reproductive and respiratory syndrome genotype I strains.Porcine reproductive and respiratory syndrome virus induces CD4+CD8+CD25+Foxp3+ regulatory T cells (Tregs).Comparison of two commercial enzyme-linked immunosorbent assays for the diagnosis of Porcine reproductive and respiratory syndrome virus infection.Commercial spray-dried porcine plasma does not transmit porcine circovirus type 2 in weaned pigs challenged with porcine reproductive and respiratory syndrome virus.Comparison of muscle fluid and serum for detection of antibodies against hepatitis E virus in slaughter pigs.In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus.Evidence of widespread infection of avian hepatitis E virus (avian HEV) in chickens from Spain.Genetic diversity and phylogenetic analysis of glycoprotein 5 of European-type porcine reproductive and respiratory virus strains in Spain.Expression of Toll-like receptor 9 (TLR9) in the lungs and lymphoid tissue of pigs.Haptoglobin and pig-major acute protein are increased in pigs with postweaning multisystemic wasting syndrome (PMWS).Lack of an effect of a commercial vaccine adjuvant on the development of postweaning multisystemic wasting syndrome (PMWS) in porcine circovirus type 2 (PCV2) experimentally infected conventional pigs.Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.Different feed withdrawal times before slaughter influence caecal fermentation and faecal Salmonella shedding in pigs.Effect of a microencapsulated feed additive of lactic and formic acid on the prevalence of Salmonella in pigs arriving at the abattoir.Testing of umbilical cords by real time PCR is suitable for assessing vertical transmission of porcine reproductive and respiratory syndrome virus under field conditions.Correction: Impact of genotype 1 and 2 of porcine reproductive and respiratory syndrome viruses on interferon-α responses by plasmacytoid dendritic cells.Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responsesImmunosuppression as a feature of postweaning multisystemic wasting syndromeImmune response development after vaccination of 1-day-old naïve pigs with a Porcine Reproductive and Respiratory Syndrome 1-based modified live virus vaccine
P50
Q28071014-458FD66B-09AB-4F4C-91F7-69A41ED4D682Q30885569-6B64A148-89D5-4C35-B1B7-E361FD7D0D89Q34569610-462EB9A3-B563-4CBB-BDE9-408C7CD4073EQ35637366-22FBDB2F-6ECC-418B-9B62-F4B0F3710CC9Q37969527-6D5BC860-1A52-465A-BEA5-C30582D45E11Q39886369-1BACD753-577E-48ED-9B55-CB70023AB46DQ40013447-E1E7D495-29BE-4C4F-9BD1-C61CE9FDBD6AQ40329853-7D8C9CDE-7052-407A-9E83-F4AB3B9F60CDQ40420514-95AEE317-3A30-43B5-B942-D796A5AD857AQ41499775-B126859F-5A5B-401E-9569-C57B891483A2Q41634768-A87DB56C-AB25-4801-A9D3-D6E2E171DA28Q42236586-DF8BCB1B-6AC3-4597-9967-CBFCCB5A95A7Q42248007-11CBA852-EBEB-43E4-9E5D-BDA3C678C304Q42602077-692E05E4-D1E6-478F-87DD-3DB22BD41C44Q42689991-8BA70E84-75D8-4642-AA96-963DE51CE197Q44453997-9D2D38AF-05BA-41C2-917B-C64C630EE485Q45359275-EFA45744-1294-47B1-AC29-64BFE28C442AQ45367712-E8460DCC-D4A6-4FA1-AFE9-AB2C1FFA2339Q45371529-501610A2-A110-423D-A465-B7E792F4359BQ45382377-D152F324-9DE2-4B91-8A08-851C5035DB0DQ45387436-4A5CAE44-22B6-4440-B04A-7903F079E589Q45729017-1AD2B57D-6E7D-446B-8A22-D63E03DF7D96Q46788434-FEB55AB9-CA74-445D-909A-073680B9F496Q47312415-BD425D76-D1F1-4CD9-B7AE-BA9D7E9E9A78Q47729768-82387699-8C6E-4FB2-8FCD-59EEA8C2C07BQ48078507-270F50A6-A319-42CC-93F6-D4F108818544Q48322353-2C010012-7555-47C6-B7F4-0FA52287A10EQ50033226-3FEC2ACF-8186-4D0D-802A-12E88B459341Q54231023-BFB9F616-7FF9-4646-BD9A-9801BAB685A3Q55717813-868D809C-B4D6-4D1F-8E5D-4F8586ABC21EQ57207435-B0F1A351-93E2-469E-A616-09CE4437EE61Q57207476-727F20A2-E938-4C9D-9817-1A7587487C32Q61801298-ACDF30EA-2E56-424C-A1F3-627B87AAD1B8
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Enric Mateu
@ast
Enric Mateu
@en
Enric Mateu
@es
Enric Mateu
@nl
type
label
Enric Mateu
@ast
Enric Mateu
@en
Enric Mateu
@es
Enric Mateu
@nl
prefLabel
Enric Mateu
@ast
Enric Mateu
@en
Enric Mateu
@es
Enric Mateu
@nl
P106
P21
P31
P496
0000-0003-2715-6032